Kamada Ltd. (KMDA)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$8.78
-1.07%
Mkt Cap $510.59M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$13.00
Range $11.00 – $15.00
Implied Upside
+48.1%
Consensus $13.00 vs current $8.78